These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17088225)

  • 21. The application of machine learning techniques as an adjunct to clinical decision making in alcohol dependence treatment.
    Connor JP; Symons M; Feeney GF; Young RM; Wiles J
    Subst Use Misuse; 2007; 42(14):2193-206. PubMed ID: 18098000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.
    Morley KC; Teesson M; Reid SC; Sannibale C; Thomson C; Phung N; Weltman M; Bell JR; Richardson K; Haber PS
    Addiction; 2006 Oct; 101(10):1451-62. PubMed ID: 16968347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Initiating acamprosate within-detoxification versus post-detoxification in the treatment of alcohol dependence.
    Kampman KM; Pettinati HM; Lynch KG; Xie H; Dackis C; Oslin DW; Sparkman T; Sharkoski T; O'Brien CP
    Addict Behav; 2009; 34(6-7):581-6. PubMed ID: 19345510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does psychosocial treatment enhance the efficacy of acamprosate in patients with alcohol problems?
    De Wildt WA; Schippers GM; Van Den Brink W; Potgieter AS; Deckers F; Bets D
    Alcohol Alcohol; 2002; 37(4):375-82. PubMed ID: 12107041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation.
    Mason BJ; Goodman AM; Chabac S; Lehert P
    J Psychiatr Res; 2006 Aug; 40(5):383-93. PubMed ID: 16546214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of acamprosate in the treatment of alcohol dependence.
    Cayley WE
    Am Fam Physician; 2011 Mar; 83(5):522-4. PubMed ID: 21391519
    [No Abstract]   [Full Text] [Related]  

  • 27. Outpatient cognitive behavioural therapy programme for alcohol dependence: impact of naltrexone use on outcome.
    Feeney GF; Young RM; Connor JP; Tucker J; McPherson A
    Aust N Z J Psychiatry; 2001 Aug; 35(4):443-8. PubMed ID: 11531723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary ethyl glucuronide and ethyl sulfate testing for recent drinking in alcohol-dependent outpatients treated with acamprosate or placebo.
    Dahl H; Hammarberg A; Franck J; Helander A
    Alcohol Alcohol; 2011; 46(5):553-7. PubMed ID: 21616946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of early and late compliance on the effectiveness of acamprosate in the treatment of alcohol dependence.
    Koeter MW; van den Brink W; Lehert P
    J Subst Abuse Treat; 2010 Oct; 39(3):218-26. PubMed ID: 20627222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alcohol dependence treatments: comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistence.
    Baser O; Chalk M; Rawson R; Gastfriend DR
    Am J Manag Care; 2011 Jun; 17 Suppl 8():S222-34. PubMed ID: 21761948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Searching for responders to acamprosate and naltrexone in alcoholism treatment: rationale and design of the PREDICT study.
    Mann K; Kiefer F; Smolka M; Gann H; Wellek S; Heinz A;
    Alcohol Clin Exp Res; 2009 Apr; 33(4):674-83. PubMed ID: 19170666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Marked reduction of heavy drinking did not reduce nicotine use over 1 year in a clinical sample of alcohol-dependent patients.
    Specka M; Lieb B; Kuhlmann T; Frommann N; Wobrock T; Schifano F; Gaebel W; Scherbaum N
    Pharmacopsychiatry; 2011 May; 44(3):120-1. PubMed ID: 21298613
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of acamprosate on psychomotor performance and driving ability in abstinent alcoholics.
    Soyka M; Aichmüller C; Preuss U; Möller HJ
    Pharmacopsychiatry; 1998 Nov; 31(6):232-5. PubMed ID: 9930638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of the atrial natriuretic peptide transcription factor GATA4 in alcohol dependence, relapse risk and treatment response to acamprosate.
    Kiefer F; Witt SH; Frank J; Richter A; Treutlein J; Lemenager T; Nöthen MM; Cichon S; Batra A; Berner M; Wodarz N; Zimmermann US; Spanagel R; Wiedemann K; Smolka MN; Heinz A; Rietschel M; Mann K
    Pharmacogenomics J; 2011 Oct; 11(5):368-74. PubMed ID: 20585342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expectancy in double-blind placebo-controlled trials: an example from alcohol dependence.
    Colagiuri B; Morley K; Boakes R; Haber P
    Psychother Psychosom; 2009; 78(3):167-71. PubMed ID: 19270472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes.
    Rösner S; Leucht S; Lehert P; Soyka M
    J Psychopharmacol; 2008 Jan; 22(1):11-23. PubMed ID: 18187529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of sleep condition and sleep-related psychological activity after cognitive-behavior and pharmacological therapy for chronic insomnia.
    Wu R; Bao J; Zhang C; Deng J; Long C
    Psychother Psychosom; 2006; 75(4):220-8. PubMed ID: 16785771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence.
    Laaksonen E; Koski-Jännes A; Salaspuro M; Ahtinen H; Alho H
    Alcohol Alcohol; 2008; 43(1):53-61. PubMed ID: 17965444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy of compliance therapy in pharmacotherapy for alcohol dependence: a randomized controlled trial.
    Reid SC; Teesson M; Sannibale C; Matsuda M; Haber PS
    J Stud Alcohol; 2005 Nov; 66(6):833-41. PubMed ID: 16459945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence: a relative benefits analysis of randomized controlled trials.
    Snyder JL; Bowers TG
    Am J Drug Alcohol Abuse; 2008; 34(4):449-61. PubMed ID: 18584575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.